U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207271
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/20/2019 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207271Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/01/2024 SUPPL-7 Labeling-Container/Carton Labels, Labeling-Package Insert

Label is not available on this site.

03/01/2024 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

06/03/2022 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

06/03/2022 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

MESALAMINE

CAPSULE, EXTENDED RELEASE;ORAL; 375MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
APRISO MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 022301 SALIX
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 216967 ALEMBIC
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 214242 ALKEM LABS LTD
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 217533 AMTA
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 214477 AUROBINDO PHARMA LTD
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 207271 MYLAN
MESALAMINE MESALAMINE 375MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 208954 ZYDUS PHARMS
Back to Top